ofatumumab 20 mg / 0.4 mL (0.4 mL INJECTION)
|
$5154.9000
|
|
VA Big4
|
|
KESIMPTA (1) |
Novartis Pharmaceuticals Corporation |
|
ofatumumab 20 mg / 0.4 mL (0.4 mL INJECTION)
|
$6812.4000
|
|
VA FSS
|
|
KESIMPTA (1) |
Novartis Pharmaceuticals Corporation |
|
ofatumumab 20 mg / 1 mL (1 mL INJECTION)
|
$86.6318
|
|
VA Big4
|
|
ARZERRA (50) |
Novartis Pharmaceuticals Corporation |
|
ofatumumab 20 mg / 1 mL (1 mL INJECTION)
|
$120.0676
|
|
VA FSS
|
|
ARZERRA (50) |
Novartis Pharmaceuticals Corporation |
|
ofatumumab 20 mg / 1 mL (1 mL INJECTION)
|
$262.4660
|
|
VA Big4
|
|
ARZERRA (5) |
Novartis Pharmaceuticals Corporation |
|
ofatumumab 20 mg / 1 mL (1 mL INJECTION)
|
$360.2040
|
|
VA FSS
|
|
ARZERRA (5) |
Novartis Pharmaceuticals Corporation |
|